Dow Down 0.02% Nasdaq Up 0.07%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
5.78 Down 0.09(1.53%) 3:59PM EST
|After Hours : 5.78 0.00 (0.00%) 4:00PM EST - Nasdaq Real Time Price
Prev Close:5.87
Open:5.90
Bid:5.77 x 1600
Ask:5.78 x 3200
1y Target Est:11.33
Beta:3.84
Next Earnings Date:N/A
Day's Range:5.76 - 6.00
52wk Range:3.11 - 7.82
Volume:3,070,944
Avg Vol (3m):4,580,880
Market Cap:711.90M
P/E (ttm):N/A
EPS (ttm):-0.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXDown 1.53%711.90M
ABTDown 0.36%66.50B
GSKUp 0.02%111.26B
RHHBYDown 0.37%252.85B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.63
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Dec-14) :0.23
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-3.77

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback